Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
26
-
Total 13F shares, excl. options
-
879,899
-
Shares change
-
+1,510
-
Total reported value, excl. options
-
$7,037,176
-
Value change
-
+$9,396
-
Number of buys
-
6
-
Number of sells
-
-10
-
Price
-
$8.00
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q4 2021
28 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q4 2021.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 879,899 shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (167,616 shares), VANGUARD GROUP INC (167,244 shares), Meristem Family Wealth, LLC (85,519 shares), OVERBROOK MANAGEMENT CORP (75,469 shares), Bleichroeder LP (62,249 shares), MORGAN STANLEY (56,474 shares), PERRITT CAPITAL MANAGEMENT INC (40,000 shares), Strategic Financial Services, Inc, (30,028 shares), GEODE CAPITAL MANAGEMENT, LLC (22,442 shares), and DIMENSIONAL FUND ADVISORS LP (19,393 shares).
This table shows the top 26 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.